Plasma EGFR mutation abundance affects clinical response to first-line EGFR-TKIs in patients with advanced non-small cell lung cancer

BACKGROUND: Activated epidermal growth factor receptor (EGFR) mutation is the main pathogenic cause of non-small cell lung cancer (NSCLC) in Asia. However, the impact of plasma EGFR mutation abundance, especially of the ultra-low abundance of EGFR mutation detected by highly sensitive techniques on...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ann Transl Med
Huvudupphovsmän: Wang, Xiaohong, Liu, Yonggang, Meng, Zhiying, Wu, Yun, Wang, Shubin, Jin, Gaowa, Qin, Yingchun, Wang, Fengyun, Wang, Jing, Zhou, Haifei, Su, Xiaoxing, Fu, Xiuhua, Wang, Xiaolan, Shi, Xiaoyu, Wen, Zhenping, Jia, Xiaoqiong, Qin, Qiong, Gao, Yongqiang, Guo, Weidong, Lu, Shun
Materialtyp: Artigo
Språk:Inglês
Publicerad: AME Publishing Company 2021
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8106032/
https://ncbi.nlm.nih.gov/pubmed/33987333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-7155
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk